Showing results (1-10 of 239) with videos related to
Sort By:
Pageof 24
Oncoimmunology|February 6, 2014
Modifying tumor-associated macrophages: An important adjunct to immunotherapyZvi G Fridlender, Steven M AlbeldaCarcinogenesis|March 20, 2012
Tumor-associated neutrophils: friend or foe?Zvi G Fridlender, Steven M AlbeldaCell Research|July 4, 2015
Promoting metastasis: neutrophils and T cells join forcesZvi G Fridlender, Steven M Albelda, Zvi GranotMolecular Therapy : the Journal of the American Society of Gene Therapy|August 5, 2010
Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanismsZvi G Fridlender, Jing Sun, Sunil Singhal, et al.The Journal of Biological Chemistry|February 2, 2010
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan)Guanjun Cheng, Jing Sun, Zvi G Fridlender, et al.Cancer Cell|September 8, 2009
Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TANZvi G Fridlender, Jing Sun, Samuel Kim, et al.Biochemical Pharmacology|August 9, 2011
Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulationJing Sun, Liang-Chuan S Wang, Zvi G Fridlender, et al.Immunology Letters|May 23, 2015
Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesotheliomaGregory T Kennedy, Brendan F Judy, Pratik Bhojnagarwala, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 9, 2008
B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor modelsSamuel Kim, Zvi G Fridlender, Robert Dunn, et al.American Journal of Hematology|December 26, 2003
Myocardial infarction in a patient with beta-thalassemia major: first reportZvi G Fridlender, Deborah RundPageof 24